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Altered Cerebellar Biochemical 
Profiles in Infants Born Prematurely
Marie Brossard-Racine1,2, Jonathan Murnick3, Marine Bouyssi-Kobar4, Janie Coulombe5, 
Taeun Chang6 & Catherine Limperopoulos4
This study aims to compare the cerebellar biochemical profiles in preterm (PT) infants evaluated 
at term equivalent age (TEA) and healthy full-term newborns using proton magnetic resonance 
spectroscopy (1H-MRS). We explore the associations between altered cerebellar metabolite profiles 
and brain injury topography, severity of injury, and prematurity-related clinical complications. We 
prospectively collected high quality 1H-MRS in 59 premature infants born ≤32 weeks and 61 healthy 
full term controls. 1H-MRS data were processed using LCModel software to calculate absolute 
metabolite concentration for N-acetyl-aspartate (NAA), choline (Cho) and creatine (Cr). PT infants had 
significantly lower cerebellar NAA (p < 0.025) and higher Cho (p < 0.001) at TEA when compared to 
healthy controls. Creatine was not different between the two groups. The presence of cerebellar injury 
was consistently associated with reduced concentrations for NAA, Cho, and Cr. Postnatal infection 
was negatively associated with NAA and Cr (p < 005), while cerebral cortical brain injury severity was 
inversely associated with both Cho and Cr (p < 0.01). We report for the first time that premature birth is 
associated with altered cerebellar metabolite profiles when compared to term born controls. Infection, 
cerebellar injury and supratentorial injury are important risk factors for impaired preterm cerebellar 
biochemistry.
Over the past fifteen years, neuroimaging studies have brought to the forefront a previously underrecognized 
prevalence of cerebellar growth impairment following preterm (PT) birth1. Conventional imaging studies first 
described a high incidence of structural cerebellar injury (CBI) in survivors of PT birth2–4. With the introduction 
of quantitative magnetic resonance imaging (MRI), secondary arrested growth of the cerebellum in the setting of 
severe, isolated supratentorial injury (SPI), has been demonstrated in the cerebellum, suggesting trophic trans-
synaptic effects of the cerebro-cerebellar pathway5–7. Even in the absence of supra- or infratentorial lesions on 
conventional MRI, cerebellar underdevelopment or hypoplasia has also been reported in survivors of prematu-
rity during adolescence and adulthood8, 9. This underdevelopment may be suggestive of genetic or chromosomal 
anomalies10 but more than likely reflects microscopic injury that is below the current level of resolution of con-
ventional MRI.
Proton magnetic resonance spectroscopy (1H-MRS) is a non-invasive imaging technique that measures in vivo 
concentrations of brain tissue metabolites. Common brain metabolites that can be accurately detected include; 
N-acetyl-aspartate (NAA), choline (Cho) and creatine (Cr). NAA is a marker of neuronal integrity11, and a reduc-
tion in concentration is associated with neuronal injury and immaturity12. Cho is a marker of membrane struc-
tural integrity and membrane turn over, and Cr is a marker of energy stores. Decreased concentration of both 
of these metabolites would indicate altered neuronal integrity13. Together, these metabolites provide important 
biochemical information on the integrity of the developing neuronal tissue. Cerebral metabolites evaluated in 
preterm infants at term equivalent age (TEA) have shown to be a promising biomarker of later neurodevelop-
ment outcomes14. However, cerebellar biochemical profiles remain to be examined. The objective of this study 
was to compare the cerebellar biochemical profiles in PT infants evaluated at TEA to healthy full-term newborns 
using 1H-MRS, and to investigate associations between cerebellar metabolite profiles, brain injury topography 
(i.e. infra- and supratentorial) and severity, and prematurity-related clinical complications.
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Results
A total of 210 cerebellar 1H-MRS acquisitions were acquired in 103 full-term controls and 94 PT infants at TEA. 
Of these, only 125 spectra (59%) met our rigorous quality assessment criteria and were included in our final anal-
yses. These included, 61 spectra from 61 controls (mean gestational age (GA) = 41.55 weeks) and 64 spectra from 
59 PT infants (mean GA = 39.91weeks) of whom five PT infants had two MRIs at TEA. All controls had a normal 
structural brain MRI. Of the 59 PT infants, 24 had no parenchymal injury, 23 had SPI only, 10 had both SPI and 
CBI, and 2 had CBI only. Intraventricular hemorrhage (IVH) was seen in 20 PT infants: 5 grade I, 7 grade II, 1 
grade III, 7 grade IV. Detailed clinical and demographic characteristics are presented in Table 1. Excluded subjects 
did not differ from the rest of the sample with respect to birthweight, gestational age at birth or at time of MRI, 
Apgar score, and MR injury severity score.
Mean differences in metabolite absolute concentrations between the two groups are summarized in Table 2. 
When controlling solely for GA at MRI, cerebellar total NAA (tNAA) was significantly lower (p = 0.025) and total 
Cho (tCho) was significantly higher (p < 0.001) in PT infants when compared to the controls. However, total Cr 
(tCr) was not significantly different between groups. After accounting for cerebellar signal abnormality (i.e. CBI) 
in the model, although metabolic differences showed the same trend, only tCho alterations remained significant 
(p < 0.001).
The best forward multiple linear regression models evaluating associations between clinical complications 
and metabolites in the PT infants are presented in Table 3. GA at MRI and the presence of CBI were respectively 
associated with increased and reduced concentration in all three metabolites. Infection was negatively associated 
with tNAA and tCr, while the combined grey matter injury severity was inversely associated with both tCho and 
tCr. No other significant associations were found among any other clinical factors.
Discussion
Our study reports altered cerebellar metabolite profiles in prematurely born infants at TEA when compared to 
healthy term controls. Alterations in absolute cerebellar metabolite concentrations were primarily observed in 
NAA and Cho but not in Cr. As expected, absolute concentrations of all three metabolites were highly associated 
with CBI. The only other clinical risk factors associated with biochemical impairments in the cerebellum were 
severity of supratentorial grey matter injury and neonatal infection.
Term (n = 61) Preterm (n = 59)
Mean ± SD/Median[range] Mean ± SD/Median[range]
Ante and neonatal
Clinical chorioamnionitis n (%) 0 (0%) 14 (23.7)
GA at birth (weeks)** 39.6 ± 1.2 26.7 ± 2.7
Birth weight (grams)** 3321 ± 364 872 ± 334
Female n (%) 28 (45.9) 33 (55.9)
Intubation at birth n (%) 0 (0%) 27 (48.2)
Apgar score 1 min**/5 min** 8[6–9]/9[8–9] 4 [1–9]/7[1–9]
Patent ductus arteriosus ligation n (%) NA 19 (32.2)
Surgery for necrotizing enterocolitis n (%) NA 29 (49.2)
Neonatal infection n (%) NA 21 (35.6)
Days on mechanical ventilation NA 30 ± 38
Days on supplementary oxygen NA 86 ± 51
Chronic lung disease n (%) NA 38 (64.4%)
Days in NICU NA 120 [30–205]
Neonatal MRI
Gestational age at MRI (weeks)** 41.5 [38.3–45.6] 39.9 [35.3–44.4]
Day of life at MRI** 12 [4–31] 96 [30–138]
White matter injury score NA 3 [0–16]
Combined grey matter injury score NA 1 [0–9]
Cerebellar score NA 1 [0–7]
Table 1. Clinical characteristics of the cohort (N = 120). Legend: **p < 0.01.
Metabolites2 Preterm Control P-values
tNAA 6.817 ± 1.936 8.282 ± 1.755 0.025
tCho 6.012 ± 1.295 5.434 ± 0.737 <0.001
tCr 9.608 ± 2.110 10.200 ± 1.721 0.693
Table 2. Absolute concentrations of brain metabolite in preterm and healthy full-term controls (Mean ± SD)1. 
Legend: 1controlling for GA at MRI; 2concentration is in mM/kg.
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To date, there is very limited published data to compare our cerebellar metabolic results. Only one previous 
study attempted to compare absolute cerebellar metabolite concentrations in a small subset of PT infants and 
full term controls with limited success due to the small number of spectra successfully obtained in this region (4 
PT vs. 7 controls)15. Our study is the first to provide evidence for altered cerebellar metabolism in a group of PT 
infants compared to an equally large number of healthy full-term controls.
In our study, we successfully obtained spectra in 12 PT infants with direct cerebellar injury. These injuries 
were overall mild, given the inherent difficulty of acquiring good quality spectra in the presence of extensive 
injury. The inclusion of too much cerebrospinal fluid (CSF) and/or residual blood product in the voxel of interest 
usually dominates the tissue’s signal and results in a failed acquisition. Similarly, when residual cerebellar volume 
is too little, the small voxel size used to capture the 1H-MRS does not provide sufficient signal-to-noise ratio 
needed to successfully obtain good quality spectra. In this subset of 12 PT infants, we found that cerebellar injury 
was associated with decreased NAA, Ch, and Cr. Reduced NAA is known to be a marker of altered neurogenesis 
or neuronal loss16, 17. Our data suggests that in the presence of CBI, cerebellar neuronal damage extends beyond 
the site of the injury and is present in regions apparently intact as evaluated by conventional MRI. Available 
evidence in PT infants suggests that lower cerebellar NAA/Cho ratio evaluated at TEA is associated with lower 
cognitive scores at 2 years of age18. However, an understanding of the true contribution of NAA is limited given 
that it cannot be separated from the variation of Cho, the denominator in ratio analyses19. We show for the first 
time in our study that absolute concentrations of Cho are not constant in PT infants, as Cho is affected by both 
CBI and SPI. Our findings therefore emphasize the limitation of using ratio analyses for interpreting metabolic 
disturbances particularly in the PT infant.
Our findings demonstrate that only Cho remained significantly higher in the PT group after controlling for 
GA at MRI and CBI. During typical cerebral development, choline concentration reaches its highest values in the 
first few months of life and steadily decreases after the relative completion of the myelin’s most important forma-
tion phase that is characteristically before 2 years of age13, 20. We previously reported reduced mean diffusivity in 
the vermis of PT without CBI when compared to healthy controls reflecting a possible increase in cellular den-
sity21. Together with our observation of increased Cho in PT by TEA, these data suggest a possible cerebellar cel-
lular/microstructural overgrowth or overexpression which may represent a compensatory mechanism triggered 
by an interruption of the cerebellum preprogrammed developmental course. Notably, cerebral and cerebellar 
overgrowth, thought to be a consequence of apoptosis failure have been previously reported in developmental 
disorders including fetal ventriculomegaly22, postnatal hydrocephalus23 and autism24, 25. However, in the absence 
of cerebellar volumetric analyses and serial prospective follow-up studies, interpretation of our cross-sectional 
observations remains speculative.
In addition to CBI, which consistently mediated all three metabolites in the PT cohort, combined supratento-
rial grey matter injury was also associated with lower Cho and Cr concentrations. Interestingly, the white matter 
injury score was not associated with lower Cho and Cr concentrations. This association may in part be explained 
by the fact that the PT infants in our sample had less overall cortical or subcortical grey matter abnormalities as 
compared to the frequent mild white matter abnormalities previously described26. Negative associations between 
Cho, Cr and cerebral cortical grey matter injury further describe the cerebro-cerebellar diaschisis effects on cer-
ebellar development. Secondary growth impairment of the cerebellum in the presence of severe SPI has been 
previously described5–7. This study adds to the existing literature by demonstrating disturbances in cerebellar 
metabolism in the preterm infant.
Our data showed that postnatal infection is also negatively associated with NAA and Cr in PT infants. 
Through elevated cytokine responses, maternal and neonatal infections are thought to be an important etiologic 
factor for periventricular white matter injury27. The negative effect of infection on cerebral NAA/Cho ratio has 
been previously described in the cerebrum of PT infants at TEA even in the absence of parenchymal injury28. 
However, this neurotoxic response had not been previously described in the cerebellum. Our relatively modest 
sample size may have limited our ability to detect more complex associations and their interactions with other 
risk factors described in our cohort.
Metabolites R2 (models’ p-values) Variables
Standardized 
coefficients
Variables’ 
p-values
tNAA 0.315 (<0.001)
GA 0.474 <0.001
Infection −0.247 0.042
CBI −0.298 0.012
tCho 0.356 (<0.001)
GA 0.384 0.001
CBI −0.349 0.002
Combined grey 
matter injury −0.381 0.001
tCr 0.514 (<0.001)
GA 0.641 <0.001
CBI −0.706 <0.001
Infection −1.075 0.015
Combined grey 
matter injury −0.273 0.017
Table 3. Best forward multiple linear regression models of clinical complications associated with cerebellar 
metabolites1. Legend: 1in mM/kg; GA, gestational age at MRI; CBI, cerebellar injury.
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Our study limitations deserve mention. Our 60% success rate in performing spectroscopy was somewhat low, 
but comparable between our control and PT infant cohorts. The overall baseline characteristics (e.g. birthweight, 
age at MRI) for excluded or failed 1H-MRS subjects did not differ from the rest of the sample. We therefore believe 
that our reduced success rate is explained in part by the fact that our 1H-MRS acquisition was at the end of our 
MRI protocol. This acquisition is particularly sensitive to motion. As our MRIs were performed during natural 
sleep (without sedation), we had several babies who woke up before or during the MRI, preventing us from com-
pleting the 1H-MRS acquisition. When interpreting our results, it is important to note that we have calculated 
our absolute concentration values assuming that our voxel only contained cerebellar white matter. Although we 
made sure that our voxel predominantly contained cerebellar white matter, due to the extensive foliation of the 
cerebellum, the position of its deep nuclei and its overall shape, we cannot overlook the possibility that our voxels 
may have been in part contaminated by a small quantity of grey matter or CSF.
In summary, this study provides the first evidence for altered cerebellar metabolic profiles in PT infants at 
TEA when compared to healthy term born infants. In keeping with the already well-documented cerebellar 
disturbances observed in the PT infants, our findings provide evidence for in vivo metabolic disturbances at a 
biochemical level. Ongoing studies with larger sample sizes and longitudinal follow-ups are needed to better 
understand how these metabolic disturbances relate to the developmental cerebellar cognitive affective syndrome 
frequently observed in surviving preterm infants.
Figure 1. Example of a single 1H-MRS voxel placed in the middle of the cerebellum on corresponding sagittal, 
coronal and axial T2 images.
Figure 2. Typical good quality LCmodel spectra output obtained in a preterm infant at 38.14 weeks of age.
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Methods
Participants. This is a prospective study of premature infants born ≤32 weeks and of ≤1500 g birth weight, 
admitted to a tertiary neonatal intensive care unit (NICU) at Children’s National Health System (CNHS) 
(Washington, D.C.) between June 2012 and February 2016. PT infants with congenital malformations or dysmor-
phic features suggestive of a genetic syndrome, chromosomal abnormality, confirmed inborn errors of metabo-
lism or central nervous system infection were excluded. Full-term control infants were recruited from a parallel 
study evaluating serial brain development in utero and postnatally in healthy full term infants (≥37 weeks) born 
without event to healthy singleton pregnant volunteers29. Volunteers with abnormal findings on either fetal ultra-
sound or postnatal brain MRI of their newborns were excluded. Ante-, peri- and postnatal information for all 
enrolled subjects were collected through review of medical records and parental questionnaires. Written informed 
consent was obtained for every participant, and the study was approved by the CNHS Institutional Review Board. 
All aspects of the study were performed in accordance with relevant institutional guidelines and regulations.
MRI acquisitions. Unless clinically indicated for PT infants, no sedation or intravenous injection of contrast 
agents were used during the infant’s MRIs. The non-sedated MRIs were performed during natural sleep after feed-
ing and swaddling the infants. All MRIs were performed on a 3 Tesla MRI scanner (Discovery MR750, General 
Electric Medical Systems-Waukesha, WI) with an 8-channel receiver head coil. PT infants were scanned when 
medically stable at TEA with a targeted GA window of 39–41 weeks. Healthy control newborns completed their 
brain MRIs as outpatients without sedation, shortly after birth.
As part of our multimodal MRI acquisition protocol, structural images (T2 3D-cube and T1 3D-SPGR) and 
1H-MRS were acquired using the exact same protocol for all preterm and full-term control infants. Each brain 
MRI study was reviewed by an experienced pediatric neuroradiologist (J.M). MRI abnormalities were scored 
using the Kidokoro et al.30 scoring system for PT infants at TEA. This scoring system uses 13 items to evalu-
ate brain maturity and injury of the cerebral white matter, cerebral cortical and deep grey matter as well as the 
cerebellum which together form the total injury score. Direct CBI was characterized by the presence of signal 
abnormality, which corresponds to a score >0 on the cerebellar signal item. In an attempt to capture the impact 
of injury localization, we used the cerebellar, white, and grey matter sub-scores separately in our analyses rather 
than the total score. Due to the relative small number of injured PT infants, we combined cortical and deep grey 
matter (Kidokoro’s subscale) to obtain an overall grey matter sub-score. Germinal matrix and intraventricular 
hemorrhages were separately graded according to Papile’s grading system31.
1H-MRS were acquired from a single voxel of 3 cm3 (1 × 3 × 1) on average placed in the middle of the cerebel-
lum avoiding the skull and extra-axial spaces (Fig. 1), using a point resolved spectroscopy (PRESS) sequence with 
a TE of 144 ms, a TR of 1500 ms, and 128 signal averages. Two additional oblique outer volume suppression pulses 
were placed to minimize unwanted signals from outside the voxel and flow artifacts from the vasculature and 
CSF1.H-MRS data were processed using LCModel software32 to calculate absolute metabolite concentrations in 
the chemical shift range of 4.0 to 1.0 ppm, using the unsuppressed water signal as an internal reference. Figures 2 
Figure 3. Typical good quality LCmodel spectra output obtained in a healthy control at 39.43 weeks of age.
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and 3 present examples of our processed spectra output. We assumed that the water absolute concentration was 
constant in the evaluated tissue and that the voxel contained only white matter. Absolute metabolite concentra-
tions were then corrected for tissue water content estimated in the cerebellum around term (88%) and calculated 
in mM/kg33.
Individual metabolite spectra were then generated for the six following compounds: Creatine (Cr), 
Phosphorecreatine (PCr), Glycerophosphorylcholine (GPC), Phosphocoline (PCh), N-Acetyl-acetylaspartate 
(NAA), and N-acetyl-aspartyl-glutamate (NAAG). The sums of the absolute metabolite concentrations 
[tNAA = NAA + NAAG, tCho = GPC + PCh, tCr = PCr + Cr] were used in the analysis since they represent 
more accurate estimates. Based on the LCModel output, MR spectra with a line width at FWHM greater than 
0.129 ppm and/or signal to noise ratio of less than three were excluded.
Statistical analysis. Descriptive statistics for both groups were performed first. Thereafter, replicates for 
individuals who had more than one 1H-MRS dataset were randomly excluded and only one observation was 
kept such that the whole set was made of independent observations. All subsequent analyses were performed 
on that subset. To assess the difference in cerebellar metabolite concentrations between the cases and controls, 
analysis of covariance was performed adjusting for GA at time of MRI and then for the presence of cerebellar 
signal abnormality. Subsequently, we wanted to explore the effect of brain injury topography and other clinical 
complications on cerebellar metabolites. In the PT group only, partial regressions were first performed in order to 
assess which variables were significantly associated to each metabolite after adjusting for GA at MRI. Univariate 
analyses explored associations between each metabolite and the following variables: histologic chorioamnionitis, 
GA at birth, intubation at birth, Apgar score at 5 minutes of life, surgery for necrotizing enterocolitis or for patent 
ductus arteriosus, clinical infection as determined by positive cultures or by treatment with antibiotics for more 
than 7 days, highest respiratory support, length of stay on oxygen, length of NICU admission, and the three 
different subscores for brain injury (i.e. combined grey matter injury, subcortical white matter injury, cerebellar 
injury). For each metabolite, a forward regression was then performed, in which all significant risk factors found 
at the previous step were used as covariates along with GA at MRI. The final models represented the best sets of 
risk factors, which were the most linked to each metabolite outcome. We used a 5% level of significance. All the 
analyses were done with SPSS v19.
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